Atlantic Center for Oral and Maxillofacial Surgery Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT01227174
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Atlantic Centre for Oral and Maxillofacial Surgery | Staff Surgeon at Atlantic Centre for Oral and Maxillofacial Surgery

Active Ingredients

Drugs in Phase 4 Trials (1)

propofol (diprivan) (1 trial)

Drugs in Other Trials (3)

cefazolin (ancef) (1 trial)

cephalexin (keflex) (1 trial)

clindamycin (cleocin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4